Top Biotech Companies in Edinburgh (29)
Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions. We have a strong track record, having advanced multiple vaccines from early R&D to approvals,...
RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. Established in 2006 and built upon the groundbreaking technology cloning of Dolly the Sheep at the Roslin Institute in 1997, RoslinCT has harnessed cutting-edge science to advance the development of human medicines. With a remarkable heritage in the field, the company...
Providing predictive analytics from suspended-cells through our unbiased cytometry technology, Cytomos® Dielectric Spectroscopy: CDS™
We’re developing the next generation of ultrafast laser sources for scientific research and industrial applications worldwide. We’ve fused together solid-state and fiber-based technology to develop a range of fixed wavelength and tunable laser sources. Our robust and compact systems ensure high stability and optimal efficiency, whereas our IP protected manufacturing know-how enables Chromacity to offer systems at affordable price points,...
MiAlgae aims to revolutionize the current livestock and pet feed industries by producing microalgae rich in polyunsaturated fatty acids (PUFAs) to offer as a replacement to fishmeal in feed. 🚫🐟 Feed suppliers are in need of this alternative to fishmeal due to declining wild fish stocks and rising demand for Omega-3s. MiAlgae has developed an environmentally beneficial, effective, and simple...
Developing precision medicines to modulate macrophages for the treatment of cancer.
Wobble Genomics is a pioneering healthcare and biotechnology company specialising in long-read RNA sequencing. Its innovative Level-Up biochemical technology enhances the detection of low-abundance RNA sequences, allowing scientists to capture all unique full-length RNA sequences in any sample. Paired with its TAMA bioinformatic technology, Wobble optimises the identification of low-level signals, using RNA biology to drive deeper insights from sequencing...
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and...
Catalent, Inc.'s Top Stability & Growth Strengths
Strong Market Position & Advantage: Independent analyses consistently place Catalent among the top global CDMOs, with meaningful presence in outsourced finished‑dose approvals and a broad end‑to‑end network. Its scale across oral, sterile, biologics, and cell & gene therapy supports late‑stage and commercial programs globally.
Investor Backing & Capital Strength: Novo Holdings’ completed acquisition provides deep‑capital sponsorship and strategic validation, with U.S./EU clearance reinforcing the platform’s importance. Related transactions around sterile sites highlight the strategic value of capabilities aligned to high‑demand medicines.
Future-Ready Strategy: Private ownership and a refreshed operating model aim to focus investment on biologics, cell & gene therapy, and clinical supply. GLP‑1–linked demand signals and capacity plans into the coming years indicate preparedness for sustained growth.
Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and the environment safer, healthier and more sustainable. From the food you eat to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe,...
At Green Bioactives, we are passionate about making a positive impact on the world by developing sustainable plant-based products using our innovative biomanufacturing platforms. Our proprietary Plant Cell Culture Technology has enabled us to revolutionise the way that plant derived ingredients are produced, using sustainable methods of cultivation without the need to destroy trees and habitats. This means we can...
Carcinotech is a MedTech company with expertise in manufacturing 3D printed micro-tumours using patient-derived biopsies, primary cells, immune cells and cancer stem cells. Carcinotech’s advanced models provide a platform for rapid, ethical, and accurate drug screening, pre-clinical and personalised medicine testing. Working with global partners, leading pharma companies, surgeons, pathologists, clinicians, and industry-leaders, the goal is to accelerate drug screening...
Based outside Edinburgh, Roslin Technologies Limited is an ambitious food and agriculture technology company which creates disruptive biotechnologies to improve how proteins are made. Our core capabilities lie in developing and commercialising a suite of unique animal stem cells and resources for the nascent global cultivated meat industry. We were the first company to commercialise pluripotent stem cells...
Aviagen is a global poultry breeding company headquartered in Huntsville, Alabama. It operates pedigree breeding programs in the United States and United Kingdom, supply bases across six continents, and operations across the UK, Europe, Turkey, Latin America, India, Australia, New Zealand, and the United States. The company supplies high-quality breeding stock and serves customers in 100 countries through more than...
Lentitek is developing solutions to help amazing therapies get to more people. Gene therapies, and gene-modified cell therapies such as CAR-T are proving themselves as incredible life changing and life saving therapies. However they face an issue with the production yield of the viral vector. Lentitek is developing solutions to improve the viral yield by 10 fold and beyond. This will...
Dexcom Corporation is a pioneer and global leader in continuous glucose monitoring (CGM). Dexcom began as a small company with a big dream: To forever change how diabetes is managed. To unlock information and insights that drive better health outcomes. Here we are 25 years later, having pioneered an industry. And we're just getting started. We are broadening our...
Dexcom's Top Stability & Growth Strengths
Strong Market Position & Advantage: Dexcom is repeatedly portrayed as a co-leader globally and the U.S. leader in CGM, supported by deep integrations with automated insulin delivery systems and a durable duopoly structure. This positioning reflects sustained adoption of its G7 platform and scale advantages.
Strong Revenue Growth: Recent results and guidance indicate consistent double-digit year-over-year growth with expanding margins. Management communications highlight ongoing momentum into 2026 supported by continued platform rollouts.
Market Expansion: The launch of an over-the-counter sensor and extended-wear G7 broaden addressable users beyond intensive insulin therapy. International uptake and clinical data in non‑insulin type 2 populations further extend the growth runway.
Quotient Sciences is a global contract research, development, and manufacturing organization (CRDMO) supporting pharmaceutical and biotechnology companies. Its integrated services span early drug development, candidate selection, first-in-human clinical studies, formulation, clinical research, and commercial manufacturing. By combining scientific expertise, data-driven solutions, and collaborative program management, the company helps emerging biotechs and large pharma advance therapies efficiently from molecule to patients.
EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome
At Rhizocore, we develop technologies to grow symbiotic fungi that enhance the growth, resilience, and carbon sequestration potential of newly planted forests and woodlands. Whether it is for woodland restoration, commercial productivity, increasing tolerance to environmental stresses or capturing more carbon, our unique approach for growing locally-sourced mycorrhizal fungi ensures local adaptability to suit our customer's sites and needs. For...
Arrayjet provides microarray instruments and services to the pharmaceutical, diagnostic and life science industries. Our unique inkjet platform combines the fastest and most reliable instrumentation on the market with the versatility to print any biological sample type onto any solid substrate. Applications range from antibody characterization to gene expression profiling and drug discovery. >> High Throughput Screen samples faster with...
Kynos Therapeutics is a clinical-stage private company developing an innovative pipeline of first-in-class kynurenine 3-monooxygenase (KMO) inhibitors. KMO plays a major role in the regulation of inflammation, acting at the interface between inflammation, immunity and metabolism. Inhibition of KMO has therapeutic potential in both acute inflammatory conditions such as acute kidney injury and acute pancreatitis and in chronic immuno-inflammatory disorders....
